Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.1173
-0.0996 (-45.92%)
At close: Dec 12, 2025, 4:00 PM EST
0.1110
-0.0063 (-5.37%)
After-hours: Dec 12, 2025, 6:34 PM EST
Applied Therapeutics Market Cap
Applied Therapeutics has a market cap or net worth of $16.93 million as of December 12, 2025. Its market cap has decreased by -98.48% in one year.
Market Cap
16.93M
Enterprise Value
21.85M
1-Year Change
-98.48%
Ranking
Category
Stock Price
$0.12
Market Cap Chart
Since May 14, 2019, Applied Therapeutics's market cap has decreased from $160.29M to $16.93M, a decrease of -89.44%. That is a compound annual growth rate of -28.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 31.30M | -68.58% |
| Dec 31, 2024 | 99.62M | -61.49% |
| Dec 29, 2023 | 258.72M | 608.33% |
| Dec 30, 2022 | 36.52M | -84.43% |
| Dec 31, 2021 | 234.63M | -52.60% |
| Dec 31, 2020 | 494.96M | -2.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 909.23B |
| Johnson & Johnson | 508.24B |
| AbbVie | 395.26B |
| UnitedHealth Group | 309.07B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 248.28B |
| Novo Nordisk | 223.42B |